Cardiovascular
Also called Moyamoya Phenomenon, Progressive Cerebral Arteriopathy of Infancy
Moyamoya Disease is a progressive, noninflamatory cerebrovascular disease causing stenosis (narrowing) of the terminal portions of the internal carotid arteries and their major branches. In response to this narrowing, the body develops abnormal collateral vessels at the base of the brain that create the characteristic 'puff of smoke' appearance on cerebral angiography.
Moyamoya Disease typically presents in two age groups: children aged 5-14 years and adults in their 40s-50s. It is more common in people of East Asian descent, particularly Japanese, Korean, and Chinese populations, though cases have been identified in all ethnic groups. The condition affects males and females equally. Familial cases account for approximately 10% of presentations, suggesting a genetic component.
Clinical trials for Moyamoya Disease focus on optimizing surgical revascularization techniques, neuroprotection strategies, and medical management of risk factors. Research is examining the role of antiplatelet therapy, anticoagulation, and newer interventions aimed at promoting collateral vessel development and stabilization. Neuroimaging advances are improving understanding of disease progression and outcomes. Patients should consult with a neuroradiologist or neurosurgeon experienced in moyamoya disease, as specialized centers often have access to research opportunities and latest treatment protocols.